Stated-preference research in HIV: a scoping review

JM Humphrey, V Naanyu, KR MacDonald… - PloS one, 2019 - journals.plos.org
Discrete choice experiments (DCE), conjoint analysis (CA), and best-worst scaling (BWS)
are quantitative techniques for estimating consumer preferences for products or services …

Patients' preferences for antiretroviral therapy service provision: a systematic review

YA Belay, M Yitayal, A Atnafu, FA Taye - Cost Effectiveness and Resource …, 2021 - Springer
Background Achieving global targets of adherence to treatment, retention in care, and
treatment success remains a challenge. Health system investment to make antiretroviral …

[HTML][HTML] Adherencia, satisfacción y calidad de vida relacionada con la salud en pacientes infectados por el VIH con tratamiento antirretroviral en España. Estudio …

JMV Cerdá, MTM Conde, RM Verdugo, MT Cortés… - Farmacia …, 2014 - Elsevier
Objetivo Determinar la relación entre satisfacción con el tratamiento antirretroviral (TAR),
adherencia y calidad de vida (CV) en pacientes adultos diagnosticados de infección por VIH …

A descriptive review on methods to prioritize outcomes in a health care context

IM Janssen, A Gerhardus… - Health …, 2015 - Wiley Online Library
Background Evidence synthesis has seen major methodological advances in reducing
uncertainty and estimating the sizes of the effects. Much less is known about how to assess …

Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods

EF Eaton, C McDavid, MK Banasiewicz… - Patient preference …, 2017 - Taylor & Francis
Objective The objective of this study was to understand patient preferences for contemporary
antiretroviral therapy (ART) by focusing on three areas that have been understudied …

Preferencias, satisfacción y adherencia con el tratamiento antirretroviral: estudio ARPAS (II)

JMV Cerdá, MAC Gómez, IE Rodríguez, OI Barrueta… - Farmacia …, 2007 - Elsevier
Objetivo Describir el estudio ARPAS y analizar las características sociodemográficas,
clínicas y las preferencias de los pacientes con el tratamiento antirretroviral (TAR), así como …

An evaluation of patient preferences for osteoporosis medication attributes: results from the PREFER-US study

TW Weiss, DT Gold, SL Silverman… - … medical research and …, 2006 - Taylor & Francis
Objective: To evaluate preferences for eight medication attributes that women may consider
when evaluating prescription osteoporosis medications. Research design and methods: The …

Concomitant use of gastric acid‐reducing agents is frequent among HIV‐1‐infected patients receiving protease inhibitor‐based highly active antiretroviral therapy*

J Van Lunzen, H Liess, K Arastéh, R Walli… - HIV …, 2007 - Wiley Online Library
Objective The aim of the study was to assess the frequency of the concurrent use of gastric
acid‐reducing agents among HIV‐1‐infected patients treated with highly active antiretroviral …

Long-term efficacy, tolerability, and renal safety of atazanavir/ritonavir-based antiretroviral therapy in a cohort of treatment-naive patients with HIV-1 infection: The …

E Teófilo, N Rocha-Pereira, B Kuhlmann… - HIV clinical …, 2016 - Taylor & Francis
Background: Boosted protease inhibitors (PIs), including ritonavir-boosted atazanavir
(ATV/r), are a recommended option for the initial treatment of HIV-1 infection based upon …

Significant improvements in self-reported gastrointestinal tolerability, quality of life, patient satisfaction, and adherence with lopinavir/ritonavir tablet formulation …

S Schrader, SK Chuck, LW Rahn, P Parekh… - AIDS research and …, 2008 - Springer
Background The tablet formulation of ritonavir-boosted lopinavir (LPV/r; Kaletra®) has many
advantages over the soft gel capsule (SGC) formulation, including lower pill count, no …